Putnam Investments LLC Sage Therapeutics, Inc. Transaction History

Putnam Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $288,629 - $398,439	10,488 New	10,488 $338,000
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $1.97 Million - $3 Million	-47,983 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $1.25 Million - $2.07 Million	47,983 New	47,983 $2 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $1.34 Million - $1.68 Million	-9,562 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $544,544 - $688,349	3,579 Added 59.82%	9,562 $1.54 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $363,287 - $1 Million	5,983	5,983 $986,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.